Vertical Pharmaceuticals, Llc

Manufacturer Details

There are currently no manufacturer details available.

Vertical Pharmaceuticals, Llc Drugs

Mercurochrome

Mercurochrome

One tablet daily or as directed by a physician.
Mucus Relief Severe Con...

Mucus Relief Severe Congestion And Cough Maximum Strength

One caplet daily or as directed by a physician.
Lorzone

Lorzone

Usual Adult Dosage

Lorzone® Tablets (chlorzoxazone USP) 375 mg:

One tablet three or four times daily. If adequate response is not obtained with this dose, the 375 mg tablets may be increased to two tablets (750 mg) three or four times daily. As improvement occurs dosage can usually be reduced.

Lorzone® Tablets (chlorzoxazone USP) 750 mg:

1/3 tablet (250 mg) three or four times daily. Initial dosage for painful musculoskeletal conditions should be 2/3 tablet (500 mg) three or four times daily. If adequate response is not obtained with this dose, it may be increased to one tablet (750 mg) three or four times daily. As improvement occurs dosage can usually be reduced.
Ibuprofen

Ibuprofen

One softgel daily or as directed by a physician.
Crest Pro-health Clinic...

Crest Pro-health Clinical Gum Protection

One softgel capsule daily or as directed by a physician.
Ibuprofen

Ibuprofen

Usual adult dose

One bisected tablet daily or as directed by a physician.
Good Neighbor Pharmacy ...

Good Neighbor Pharmacy Sleep Time

Generally, when estrogen is prescribed for a postmenopausal woman with a uterus, a progestin should also be considered to reduce the risk of endometrial cancer.

A woman without a uterus does not need a progestin. In some cases, however, hysterectomized women with a history of endometriosis may need a progestin [see Warnings and Precautions (5.2, 5.14)].

Use of estrogen-alone, or in combination with a progestin, should be with the lowest effective dose and for the shortest duration consistent with treatment goals and risks for the individual woman. Postmenopausal women should be re-evaluated periodically as clinically appropriate to determine if treatment is still necessary.

2.1 Treatment of Moderate to Severe Vasomotor Symptoms due to Menopause

Divigel should be applied once daily on the skin of either the right or left upper thigh. The application surface area should be about 5 by 7 inches (approximately the size of two palm prints). The entire contents of a unit dose packet should be applied each day. To avoid potential skin irritation, Divigel should be applied to the right or left upper thigh on alternating days. Divigel should not be applied on the face, breasts, or irritated skin or in or around the vagina. After application, the gel should be allowed to dry before dressing. The application site should not be washed within 1 hour after applying Divigel. Contact of the gel with eyes should be avoided. Hands should be washed after application.

Generally, women should be started at the 0.25 gram dosage strength.
Publix Ultradish Deterg...

Publix Ultradish Detergent

Usual adult dose: One bisected tablet daily or as directed by a physician.
Amoxicillin

Amoxicillin

Usual adult dose is 1 tablet daily, or as directed by a physician.
Conzip

Conzip

2.1 General Dosing Considerations

ConZip® is an extended-release formulation intended for once a day dosing in adults aged 18 years and older. The capsules must be swallowed whole with liquid and must not be split, chewed, dissolved or crushed. Chewing, crushing or splitting the capsule could result in the uncontrolled delivery of tramadol, in overdose and death [see WARNINGS AND PRECAUTIONS (5.11), DRUG ABUSE AND DEPENDENCE (9), and OVERDOSE (10.1)].

Do not administer ConZip® at a dose exceeding 300 mg per day. Do not use ConZip® more than once daily or concomitantly with other tramadol products [see WARNINGS AND PRECAUTIONS (5.12)].

2.2 Patients Not Currently on Tramadol Immediate-Release Products

Initiate treatment with ConZip® at a dose of 100 mg once daily and titrated up as necessary by 100 mg increments every five days to achieve a balance between relief of pain and tolerability.

2.3 Patients Currently on Tramadol Immediate-Release Products

Calculate the 24-hour tramadol IR dose and initiate a total daily dose of ConZip® rounded down to the next lowest 100 mg increment. The dose may subsequently be individualized according to patient need. Due to limitations in flexibility of dose selection with ConZip®, some patients maintained on tramadol IR products may not be able to convert to ConZip®.

2.4 Patients 65 Years of Age and Older

Initiate dosing of an elderly patient (over 65 years of age) should be initiated cautiously, usually starting at the low end of the dosing range, reflecting the greater frequency of decreased hepatic, renal or cardiac function and of concomitant disease or other drug therapy. ConZip® should be administered with even greater caution in patients over 75 years, due to the greater frequency of adverse events seen in this population.

2.5 Patients with Renal Impairment

The limited availability of dose strengths and once daily dosing of ConZip® do not permit the dosing flexibility required for safe use in patients with severe renal impairment. Do not use ConZip® in patients with creatinine clearance less than 30 mL/min [see USE IN SPECIFIC POPULATIONS (8.6) and CLINICAL PHARMACOLOGY (12.3)].

2.6 Patients with Hepatic Impairment

The limited availability of dose strengths and once daily dosing of tramadol hydrochloride extended-release capsules do not permit the dosing flexibility required for safe use in patients with severe hepatic impairment. Do not use ConZip® in patients with severe hepatic impairment (Child-Pugh Class C) [see USE IN SPECIFIC POPULATIONS (8.7) and CLINICAL PHARMACOLOGY (12.3)].

2.7 Discontinuation of Treatment

Withdrawal symptoms may occur if ConZip® is discontinued abruptly. Clinical experience with tramadol suggests that withdrawal symptoms may be reduced by tapering ConZip® [see WARNINGS AND PRECAUTIONS (5.10) and DRUG ABUSE AND DEPENDENCE (9.3)].

2.8 Food Effects

ConZip® may be taken without regard to food [see CLINICAL PHARMACOLOGY (12.3)].

Vertical Pharmaceuticals, Llc

Manufacturer Details

Share This Page

Vertical Pharmaceuticals, Llc Drugs